2,485 Shares in HealthEquity, Inc. (NASDAQ:HQY) Acquired by Venturi Wealth Management LLC

Venturi Wealth Management LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, HoldingsChannel reports. The firm purchased 2,485 shares of the company’s stock, valued at approximately $238,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. CIBC Asset Management Inc increased its stake in shares of HealthEquity by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 2,640 shares of the company’s stock valued at $253,000 after acquiring an additional 139 shares in the last quarter. Sanctuary Advisors LLC increased its stake in shares of HealthEquity by 5.0% in the 4th quarter. Sanctuary Advisors LLC now owns 3,335 shares of the company’s stock valued at $320,000 after acquiring an additional 159 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of HealthEquity by 8.5% in the 4th quarter. Principal Financial Group Inc. now owns 262,968 shares of the company’s stock valued at $25,232,000 after acquiring an additional 20,563 shares in the last quarter. Congress Asset Management Co. bought a new stake in shares of HealthEquity in the 4th quarter valued at $2,444,000. Finally, Rhumbline Advisers increased its stake in shares of HealthEquity by 0.4% in the 4th quarter. Rhumbline Advisers now owns 267,288 shares of the company’s stock valued at $25,646,000 after acquiring an additional 1,011 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the transaction, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 39,000 shares of company stock valued at $3,895,788. 2.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Barrington Research lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Royal Bank of Canada lifted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group began coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. Finally, BTIG Research boosted their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.71.

HealthEquity Price Performance

HQY opened at $108.60 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market capitalization of $9.41 billion, a price-to-earnings ratio of 99.63, a P/E/G ratio of 1.63 and a beta of 0.55. The firm’s fifty day moving average price is $103.66 and its two-hundred day moving average price is $92.05. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the previous year, the company earned $0.40 earnings per share. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.